Cite
HARVARD Citation
Denkert, C. et al. (2021). Clinical and molecular characteristics of HER2-low-positive breast cancer: pooled analysis of individual patient data from four prospective, neoadjuvant clinical trials. Lancet oncology. 22 (8), pp. 1151-1161. [Online].